September 30, 2020
A research programme led by US-based non-profit medical centre Mayo Clinic and UK health tech firm Ultromics will apply AI to forecast heart failure.
The team will use AI analysis of ultrasound heart scans to identify the markers of heart failure and alert doctors to potential heart failure.
WHY IT MATTERS
The aim is to develop a diagnostic and predictive tool that can reduce misdiagnosis and...
June 17, 2020
On Monday Ultromics, maker of an AI-supported cardiac-decision-support tool, scored $10 million in funding. Oxford Sciences Innovation led the round with participation from Mayo Clinic.
This comes just two years after the startup scored £10m in a Series A round also led by Oxford Sciences Innovation.
WHAT THEY DO
Founded in 2017, this Oxford University spinout is currently focused on creating...
December 4, 2019
British health tech firm Mindwave Ventures has announced this morning that it plans to open an office in Leeds, one of the biggest cities in the UK, after appointing Dr Victoria Betton and Dr Janak Gunatilleke to the roles of chief innovation officer and chief operating officer, respectively.
Since its founding in 2014, the company has worked with six NHS trusts and a sustainability and...
The 510 (K) clearance, pre-market submission, will enable the business to make EchoGo available to clinicians and healthcare providers in the US.
November 18, 2019
UK-based health technology firm Ultromics has received clearance from the US Food and Drug Administration (FDA) for its cardiovascular image analysis system, EchoGo Core.
EchoGo applies artificial intelligence (AI) to automate the analysis and quantification of ultrasound-based heart scans.
The 510 (K) clearance, pre-market submission, will enable the business to make EchoGo available to...